| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |